Bvf Investments Llc - Net Worth and Insider Trading

Bvf Investments Llc Net Worth

The estimated net worth of Bvf Investments Llc is at least $10,218 dollars as of 2024-11-10. Bvf Investments Llc is the of Capstone Holding Corp and owns about 3,193 shares of Capstone Holding Corp (CAPS) stock worth over $10,218. Details can be seen in Bvf Investments Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Bvf Investments Llc has not made any transactions after 2011-07-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Bvf Investments Llc

Bvf Investments Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Bvf Investments Llc owns 18 companies in total, including Capstone Holding Corp (CAPS) , ChemoCentryx Inc (CCXI) , and Catalyst Biosciences Inc (CBIO) among others .

Click here to see the complete history of Bvf Investments Llc’s form 4 insider trades.

Insider Ownership Summary of Bvf Investments Llc

Ticker	Comapny	Transaction Date	Type of Owner
CAPS	Capstone Holding Corp	2011-07-11	10 percent owner & other: Direct Beneficial Owner
CCXI	ChemoCentryx Inc	2012-08-28	10 percent owner
CBIO	Catalyst Biosciences Inc	2009-07-09	other: Direct Beneficial Owner
		2008-11-06	10 percent owner & other: Direct Beneficial Owners
		2011-10-05	other: See Explanation of Responses
		2013-05-01	other: See Explanation of Responses
		2008-02-20	10 percent owner & other: Direct Beneficial Owner
		2010-04-05	other: Direct Beneficial Owner
		2009-12-22	other: Direct Beneficial Owner
		2009-12-18	10 percent owner
		2009-10-21	other: Direct Beneficial Owner
		2008-10-23	10 percent owner & other: Indirect Beneficial Owners
		2009-05-15	10 percent owner & other: Group Member
		2009-02-03	10 percent owner & other: Indirect Beneficial Owners
		2006-06-06	10 percent owner & other: Indirect Beneficial Owner
		2006-01-12	other: Direct Beneficial Owner
		2004-07-07	other: Direct Beneficial Owner
		2003-10-27	other: Direct Beneficial Owner

Bvf Investments Llc Latest Holdings Summary

Bvf Investments Llc currently owns a total of 1 stock. Bvf Investments Llc owns 3,193 shares of Capstone Holding Corp (CAPS) as of July 11, 2011, with a value of $10,218.

Latest Holdings of Bvf Investments Llc

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
CAPS	Capstone Holding Corp	2011-07-11	3,193	3.20	10,218

Holding Weightings of Bvf Investments Llc

Bvf Investments Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Bvf Investments Llc has made a total of 0 transactions in Capstone Holding Corp (CAPS) over the past 5 years. The most-recent trade in Capstone Holding Corp is the acquisition of 9 shares on July 11, 2011, which cost Bvf Investments Llc around $2,250.

Insider Trading History of Bvf Investments Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Bvf Investments Llc Trading Performance

GuruFocus tracks the stock performance after each of Bvf Investments Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bvf Investments Llc is -18.46%. GuruFocus also compares Bvf Investments Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bvf Investments Llc within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Bvf Investments Llc's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Bvf Investments Llc

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	11.54
Relative Return to S&P 500(%)	22.67

Bvf Investments Llc Ownership Network

Ownership Network List of Bvf Investments Llc

No Data

Ownership Network Relation of Bvf Investments Llc

Bvf Investments Llc Owned Company Details

What does Capstone Holding Corp do?

Who are the key executives at Capstone Holding Corp?

Bvf Investments Llc is the 10 percent owner & other: Direct Beneficial Owner of Capstone Holding Corp. Other key executives at Capstone Holding Corp include other: See Remarks Alimco Financial Corp , 10 percent owner Neil S Subin , and 10 percent owner Miller Lloyd I Iii .

Capstone Holding Corp (CAPS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Capstone Holding Corp (CAPS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Capstone Holding Corp (CAPS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Capstone Holding Corp (CAPS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Capstone Holding Corp Insider Transactions

No Available Data

What does ChemoCentryx Inc do?

Who are the key executives at ChemoCentryx Inc?

Bvf Investments Llc is the 10 percent owner of ChemoCentryx Inc. Other key executives at ChemoCentryx Inc include SVP Finance & CFO & Secretary Susan M Kanaya , director & 10 percent owner & President & CEO and Director Thomas J. Schall , and SVP & Finance & Acctg Officer Yi Ching Yau .

ChemoCentryx Inc (CCXI) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ChemoCentryx Inc (CCXI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ChemoCentryx Inc (CCXI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ChemoCentryx Inc (CCXI)'s detailed insider trading history can be found in Insider Trading Tracker table.

ChemoCentryx Inc Insider Transactions

No Available Data

What does Catalyst Biosciences Inc do?

Who are the key executives at Catalyst Biosciences Inc?

Bvf Investments Llc is the other: Direct Beneficial Owner of Catalyst Biosciences Inc. Other key executives at Catalyst Biosciences Inc include director & Chief Executive Officer Charles C Wu , director & President Songjiang Ma , and Chief Operating Officer Weiguo Ye .

Catalyst Biosciences Inc (CBIO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Catalyst Biosciences Inc (CBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Catalyst Biosciences Inc (CBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Catalyst Biosciences Inc (CBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Catalyst Biosciences Inc Insider Transactions

No Available Data

What does Ligand Pharmaceuticals Inc do?

Who are the key executives at Ligand Pharmaceuticals Inc?

Bvf Investments Llc is the 10 percent owner & other: Direct Beneficial Owners of Ligand Pharmaceuticals Inc. Other key executives at Ligand Pharmaceuticals Inc include CHIEF LEGAL OFFICER & Andrew Reardon , VP & Finance and CFO Matthew E Korenberg , and Chief Financial Officer Octavio Espinoza .

Ligand Pharmaceuticals Inc (LGND) Insider Trades Summary

Over the past 18 months, Bvf Investments Llc made no insider transaction in Ligand Pharmaceuticals Inc (LGND). Other recent insider transactions involving Ligand Pharmaceuticals Inc (LGND) include a net sale of 70,748 shares made by Matthew E Korenberg , a net sale of 14,708 shares made by Octavio Espinoza , and a net sale of 13,500 shares made by Andrew Reardon .

In summary, during the past 3 months, insiders sold 39,680 shares of Ligand Pharmaceuticals Inc (LGND) in total and bought 0 shares, with a net sale of 39,680 shares. During the past 18 months, 106,227 shares of Ligand Pharmaceuticals Inc (LGND) were sold and 6,500 shares were bought by its insiders, resulting in a net sale of 99,727 shares.

Ligand Pharmaceuticals Inc (LGND)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ligand Pharmaceuticals Inc Insider Transactions

No Available Data

What does Palatin Technologies Inc do?

Who are the key executives at Palatin Technologies Inc?

Bvf Investments Llc is the other: See Explanation of Responses of Palatin Technologies Inc. Other key executives at Palatin Technologies Inc include Executive Vice President & CFO Stephen T Wills , director & President and CEO Carl Spana , and director & Exec. VP Research and Devel. Perry B Molinoff .

Palatin Technologies Inc (PTN) Insider Trades Summary

Over the past 18 months, Bvf Investments Llc made no insider transaction in Palatin Technologies Inc (PTN). Other recent insider transactions involving Palatin Technologies Inc (PTN) include a net sale of 9,997 shares made by Stephen T Wills , a net sale of 5,700 shares made by Deveer Robert K Jr , and a net sale of 200 shares made by Alan W Dunton .

In summary, during the past 3 months, insiders sold 0 shares of Palatin Technologies Inc (PTN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 21,897 shares of Palatin Technologies Inc (PTN) were sold and 6,000 shares were bought by its insiders, resulting in a net sale of 15,897 shares.

Palatin Technologies Inc (PTN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Palatin Technologies Inc Insider Transactions

No Available Data

What does Rigel Pharmaceuticals Inc do?

Who are the key executives at Rigel Pharmaceuticals Inc?

Bvf Investments Llc is the other: See Explanation of Responses of Rigel Pharmaceuticals Inc. Other key executives at Rigel Pharmaceuticals Inc include EVP & Chief Financial Officer Dean L Schorno , Sr VP of Bus Dev and Com Ops Raul R Rodriguez , and EVP & Chief Commercial Officer David A Santos .

Rigel Pharmaceuticals Inc (RIGL) Insider Trades Summary

Over the past 18 months, Bvf Investments Llc made no insider transaction in Rigel Pharmaceuticals Inc (RIGL). Other recent insider transactions involving Rigel Pharmaceuticals Inc (RIGL) include a net sale of 52,894 shares made by Raul R Rodriguez , a net sale of 14,519 shares made by David A Santos , and a net sale of 12,628 shares made by Dean L Schorno .

In summary, during the past 3 months, insiders sold 0 shares of Rigel Pharmaceuticals Inc (RIGL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 8,004 shares of Rigel Pharmaceuticals Inc (RIGL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 8,004 shares.

Rigel Pharmaceuticals Inc (RIGL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Rigel Pharmaceuticals Inc Insider Transactions

No Available Data

What does Neurocrine Biosciences Inc do?

Who are the key executives at Neurocrine Biosciences Inc?

Bvf Investments Llc is the 10 percent owner & other: Direct Beneficial Owner of Neurocrine Biosciences Inc. Other key executives at Neurocrine Biosciences Inc include Chief Corp. Affairs Officer David W. Boyer , Chief Regulatory Officer Ingrid Delaet , and Chief Financial Officer Matt Abernethy .

Neurocrine Biosciences Inc (NBIX) Insider Trades Summary

Over the past 18 months, Bvf Investments Llc made no insider transaction in Neurocrine Biosciences Inc (NBIX). Other recent insider transactions involving Neurocrine Biosciences Inc (NBIX) include a net sale of 32,776 shares made by Ingrid Delaet , a net sale of 58,181 shares made by Darin Lippoldt , and a net sale of 55,568 shares made by Julie Cooke .

In summary, during the past 3 months, insiders sold 51,819 shares of Neurocrine Biosciences Inc (NBIX) in total and bought 0 shares, with a net sale of 51,819 shares. During the past 18 months, 993,959 shares of Neurocrine Biosciences Inc (NBIX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 993,959 shares.

Neurocrine Biosciences Inc (NBIX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Neurocrine Biosciences Inc Insider Transactions

No Available Data

What does Arqule Inc do?

Who are the key executives at Arqule Inc?

Bvf Investments Llc is the other: Direct Beneficial Owner of Arqule Inc. Other key executives at Arqule Inc include director & Chief Executive Officer Paolo Pucci , CFO and Treasurer Marc Schegerin , and See Remarks Brian Schwartz .

Arqule Inc (ARQL) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Arqule Inc (ARQL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Arqule Inc (ARQL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Arqule Inc (ARQL)'s detailed insider trading history can be found in Insider Trading Tracker table.

Arqule Inc Insider Transactions

No Available Data

What does EPIRUS Biopharmaceuticals Inc do?

Who are the key executives at EPIRUS Biopharmaceuticals Inc?

Bvf Investments Llc is the other: Direct Beneficial Owner of EPIRUS Biopharmaceuticals Inc. Other key executives at EPIRUS Biopharmaceuticals Inc include Chief Business Officer Vincent Aurentz , Chief Financial Officer Thomas A. Shea , and director & Chief Executive Officer Amit Munshi .

EPIRUS Biopharmaceuticals Inc (EPRSQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of EPIRUS Biopharmaceuticals Inc (EPRSQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of EPIRUS Biopharmaceuticals Inc (EPRSQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

EPIRUS Biopharmaceuticals Inc (EPRSQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

EPIRUS Biopharmaceuticals Inc Insider Transactions

No Available Data

What does MediciNova Inc do?

Who are the key executives at MediciNova Inc?

Bvf Investments Llc is the 10 percent owner of MediciNova Inc. Other key executives at MediciNova Inc include Chief Financial Officer Jason J Kruger , Chief Financial Officer Douglas Paulin , and Chief Scientific Officer Gaeta Federico C.a. .

MediciNova Inc (MNOV) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of MediciNova Inc (MNOV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MediciNova Inc (MNOV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

MediciNova Inc (MNOV)'s detailed insider trading history can be found in Insider Trading Tracker table.

MediciNova Inc Insider Transactions

No Available Data

What does Neurobiological Technologies Inc do?

Who are the key executives at Neurobiological Technologies Inc?

Bvf Investments Llc is the other: Direct Beneficial Owner of Neurobiological Technologies Inc. Other key executives at Neurobiological Technologies Inc include 10 percent owner Ariel Warszawski , 10 percent owner Ryan Heslop , and 10 percent owner Firefly Management Co Gp, Llc .

Neurobiological Technologies Inc (NTII) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Neurobiological Technologies Inc (NTII) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Neurobiological Technologies Inc (NTII) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Neurobiological Technologies Inc (NTII)'s detailed insider trading history can be found in Insider Trading Tracker table.

Neurobiological Technologies Inc Insider Transactions

No Available Data

What does Dynavax Technologies Corp do?

Who are the key executives at Dynavax Technologies Corp?

Bvf Investments Llc is the 10 percent owner & other: Indirect Beneficial Owners of Dynavax Technologies Corp. Other key executives at Dynavax Technologies Corp include Principal Accounting Officer Justin Burgess , Chief Medical Officer and VP Robert Janssen , and Senior Vice President David F Novack .

Dynavax Technologies Corp (DVAX) Insider Trades Summary

Over the past 18 months, Bvf Investments Llc made no insider transaction in Dynavax Technologies Corp (DVAX). Other recent insider transactions involving Dynavax Technologies Corp (DVAX) include a net sale of 169,000 shares made by David F Novack , a net sale of 46,327 shares made by Robert Janssen , and a net sale of 3,000,000 shares made by Hack Andrew A. F. .

In summary, during the past 3 months, insiders sold 0 shares of Dynavax Technologies Corp (DVAX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,247,529 shares of Dynavax Technologies Corp (DVAX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,247,529 shares.

Dynavax Technologies Corp (DVAX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Dynavax Technologies Corp Insider Transactions

No Available Data

What does Repligen Corp do?

Who are the key executives at Repligen Corp?

Bvf Investments Llc is the 10 percent owner & other: Group Member of Repligen Corp. Other key executives at Repligen Corp include director & Chief Executive Officer Anthony Hunt , Senior VP & R&D Ralf Kuriyel , and SVP & Global Operations & IT James Bylund .

Repligen Corp (RGEN) Insider Trades Summary

Over the past 18 months, Bvf Investments Llc made no insider transaction in Repligen Corp (RGEN). Other recent insider transactions involving Repligen Corp (RGEN) include a net sale of 56,970 shares made by Anthony Hunt , a net sale of 15,130 shares made by Ralf Kuriyel , and a net sale of 1,850 shares made by Karen A Dawes .

In summary, during the past 3 months, insiders sold 22,191 shares of Repligen Corp (RGEN) in total and bought 0 shares, with a net sale of 22,191 shares. During the past 18 months, 84,111 shares of Repligen Corp (RGEN) were sold and 4,815 shares were bought by its insiders, resulting in a net sale of 79,296 shares.

Repligen Corp (RGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Repligen Corp Insider Transactions

No Available Data

What does Curis Inc do?

Who are the key executives at Curis Inc?

Bvf Investments Llc is the 10 percent owner & other: Indirect Beneficial Owners of Curis Inc. Other key executives at Curis Inc include CDO Jonathan B. Zung , CFO Diantha Duvall , and Head of Research & Development Robert Martell .

Curis Inc (CRIS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Curis Inc (CRIS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Curis Inc (CRIS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Curis Inc (CRIS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Curis Inc Insider Transactions

No Available Data

What does Aeolus Pharmaceuticals Inc do?

Who are the key executives at Aeolus Pharmaceuticals Inc?

Bvf Investments Llc is the 10 percent owner & other: Indirect Beneficial Owner of Aeolus Pharmaceuticals Inc. Other key executives at Aeolus Pharmaceuticals Inc include President and CEO John L Mcmanus , Chief Financial Officer Russell Skibsted , and 10 percent owner Mark Lappe .

Aeolus Pharmaceuticals Inc (AOLS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aeolus Pharmaceuticals Inc (AOLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aeolus Pharmaceuticals Inc (AOLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aeolus Pharmaceuticals Inc (AOLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aeolus Pharmaceuticals Inc Insider Transactions

No Available Data

What does AMAG Pharmaceuticals Inc do?

Who are the key executives at AMAG Pharmaceuticals Inc?

Bvf Investments Llc is the other: Direct Beneficial Owner of AMAG Pharmaceuticals Inc. Other key executives at AMAG Pharmaceuticals Inc include 10 percent owner Camber Capital Management Lp , Chief Operating Officer Anthony Casciano , and Interim CFO Brian Piekos .

AMAG Pharmaceuticals Inc (AMAG) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of AMAG Pharmaceuticals Inc (AMAG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AMAG Pharmaceuticals Inc (AMAG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AMAG Pharmaceuticals Inc (AMAG)'s detailed insider trading history can be found in Insider Trading Tracker table.

AMAG Pharmaceuticals Inc Insider Transactions

No Available Data

What does Arena Pharmaceuticals Inc do?

Who are the key executives at Arena Pharmaceuticals Inc?

Bvf Investments Llc is the other: Direct Beneficial Owner of Arena Pharmaceuticals Inc. Other key executives at Arena Pharmaceuticals Inc include director & President and CEO Amit Munshi , EVP & Chief Commercial Officer Robert Lisicki , and Executive VP and CBO Vincent Aurentz .

Arena Pharmaceuticals Inc (ARNA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Arena Pharmaceuticals Inc (ARNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Arena Pharmaceuticals Inc (ARNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Arena Pharmaceuticals Inc (ARNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Arena Pharmaceuticals Inc Insider Transactions

No Available Data

What does BioCryst Pharmaceuticals Inc do?

Who are the key executives at BioCryst Pharmaceuticals Inc?

Bvf Investments Llc is the other: Direct Beneficial Owner of BioCryst Pharmaceuticals Inc. Other key executives at BioCryst Pharmaceuticals Inc include Chief Financial Officer Anthony Doyle , Vice President and CCO Charles K Gayer , and VP & General Counsel & Corp Sec Alane P Barnes .

BioCryst Pharmaceuticals Inc (BCRX) Insider Trades Summary

Over the past 18 months, Bvf Investments Llc made no insider transaction in BioCryst Pharmaceuticals Inc (BCRX). Other recent insider transactions involving BioCryst Pharmaceuticals Inc (BCRX) include a net sale of 8,689 shares made by Machelle Sanders , a net sale of 7,866 shares made by Nancy J Hutson , and a net purchase of 36,300 shares made by Anthony Doyle .

In summary, during the past 3 months, insiders sold 0 shares of BioCryst Pharmaceuticals Inc (BCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 36,853 shares of BioCryst Pharmaceuticals Inc (BCRX) were sold and 183,601 shares were bought by its insiders, resulting in a net purchase of 146,748 shares.

BioCryst Pharmaceuticals Inc (BCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

BioCryst Pharmaceuticals Inc Insider Transactions

No Available Data

Bvf Investments Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Bvf Investments Llc. You might contact Bvf Investments Llc via mailing address: 1 Sansome St, 30th Fl, San Francisco Ca 94104.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.